Assay

Details for Australian Patent Application No. 2004254028 (hide)

Owner Orion Diagnostica Oy

Inventors Haapalahti, Jouko; Ruskoaho, Heikki; Leppaluoto, Juhani; Vuolteenaho, Olli; Ala-Kopsala, Minna

Agent Davies Collison Cave

Pub. Number AU-B-2004254028

PCT Pub. Number WO2005/003764

Priority 0315291.5 30.06.03 GB

Filing date 28 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 14 October 2010

International Classifications

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07K 14/58 (2006.01) Peptides having more than 20 amino acids

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C07K 16/26 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/003764 Priority application(s): WO2005/003764

14 October 2010 Application Accepted

  Published as AU-B-2004254028

10 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004254043-Specific method of prostate cancer detection based on PCA3 gene, and kits therefor

2004254014-DNA-based aptamers for human cathepsin g